Month: February 2012

Merck completes the sale of its production plant in Colombia Altea pharmaceutical s.a. -Colombia production plant will continue producing Merck products for both the local market and export -all employees of the plant have been transferred to Altea pharmaceutical S.A -Merck S.A. will continue expanding in Colombia chemical and Merck Serono, Consumer Health Care Business BogotáColombia, February 2012.- Merck S.A., the Colombian subsidiary of Merck KGaA, Germany, announced last Friday that has recently completed the sale of its pharmaceutical plant in Bogotá to Altea pharmaceutical S.A. Ambas companies signed a definitive agreement whereby Altea pharmaceutical S.A. acquired Merck S.A. in Bogot production facilitiesá and continue providing products of Merck for sale in Colombia and other Latin American countries. The agreement also provides for the transfer of all employees working in the old production plant of Merck S.A. to Altea pharmaceutical S.A. All the transferred employees maintain their current employment conditions. The management of Merck S.A. is convinced of having found in Altea pharmaceutical S.A. the ideal partner for the transfer of the plant’s production. “Can be sure that the quality of the manufacturing process will be maintained and that Altea pharmaceutical S.A. will continue offering excellent products to Merck and other companies of renowned in the region of Latin America.” We expect a relationship mutually beneficial. “, said Hernan Briceño, Director General of Merck S.A. in Colombia.” The strategic...